SBRT and Hormone Therapy May Delay Advanced Prostate Cancer Progression
Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study.
Stay updated with breaking news from Honorary Reader. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study.
Princess of Wales is among a growing numbers of young cancer patients. Scientists say reason for surge remains a 'mystery'.
Sediments beneath mangrove forests, saltmarshes and seagrass meadows are rich in organic carbon
Risk Training is a global training provider powered by the editorial excellence of Risk.net. Our Live Virtual training courses provide practical guidance on the latest insights, innovations, and challenges across risk management, regulation, and derivatives.
Build on your understanding of best practices for designing, executing, utilising risk assessments within your risk management framework.